Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014

Eur Urol. 2015 Aug;68(2):e31-2. doi: 10.1016/j.eururo.2015.02.044. Epub 2015 Mar 12.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Mutation
  • Neoadjuvant Therapy*
  • Prostatic Neoplasms
  • Urinary Bladder Neoplasms*